Tempest Therapeutics: H.C. Wainwright cuts target price to $7 from $11
TPST•H.C. Wainwright cut its target price for Tempest Therapeutics to $7 from $11.
Related News
Copper slips on stronger dollar, Chile supply worries cap downside
XLB•
Meta's Charm gadget carries CEO Zuckerberg's big AI ambitions
META•
Trump-Xi summit in Washington begins with great fanfare but low expectations
SPY•
Fingermotion receives indications of interest for up to 52.5 MW in 99 MW Alberta program
FNGR•
Nasdaq halts trading in ATGL for volatility at 11:11 a.m.
ATGL•